29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
Colorado employers will soon face two big changes that will impact your workplaces. In a matter of w...
Read More >
The enforceability of pre-injury liability waivers signed by parents on behalf of a minor child has ...
Read More >
Driving a massive commercial 18-wheeler is a little more complicated than driving a Honda Civic, or ...
Read More >
The Mississippi Commission on Environmental Quality (“MCEQ”) and Little Bluff, LLC, (“Little Bluf...
Read More >
With a constantly evolving legal landscape, colleges, universities and independent schools encounter...
Read More >
On January 7, 2020, the Department of Labor’s Wage and Hour Division (DOL) released two opinion let...
Read More >